Table 2.

Serious adverse events summary.

	Sham (N = 15)		Low-dose tDCS (N = 13)		High-dose tDCS (N = 14)		Overall (N = 42)
	N	%	N	%	N	%	N	%
At least one serious adverse event	4	27	1	8	2	14	7	17
	0	0	0	0	0	0	0	0
Maximum severity experienced	0	0	0	0	0	0	0	0
Mild	1	7	0	0	1	7	2	5
Moderate	1	7	0	0	0	0	1	2
Severe	1	7	0	0	0	0	1	2
Life threatening/disabling	0	0	0	0	0	0	0	0
Fatal	1	7	1	8	1	7	3	7
Related to stroke	1	100	1	100	1	100	3	100
Not Related to stroke	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0
Maximum relationship to study intervention	4	27	1	8	2	14	7	17
Unrelated	3	75	1	100	2	100	6	86
Unlikely	0	0	0	0	0	0	0	0
Possible	1	25	0	0	0	0	1	14
Probable	0	0	0	0	0	0	0	0
Definite	0	0	0	0	0	0	0	0